An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bionano Genomics, Inc. will present at the RBC Capital Markets 2024 Global Healthcare Conference, with Erik Holmlin, PhD, as the presenter. The conference will take place on May 15, 2024, and a replay will be available on the Bionano website.
Bionano Genomics, Inc. si presenterà alla Conferenza Globale sulla Sanità 2024 di RBC Capital Markets, con Erik Holmlin, PhD, come relatore. La conferenza si terrà il 15 maggio 2024 e sarà possibile visualizzare una registrazione sul sito web di Bionano.
Bionano Genomics, Inc. participará en la Conferencia Global de Salud 2024 de RBC Capital Markets, siendo Erik Holmlin, PhD, el ponente. El evento tendrá lugar el 15 de mayo de 2024 y se podrá acceder a una repetición en el sitio web de Bionano.
Bionano Genomics, Inc.는 2024년 5월 15일에 열리는 RBC Capital Markets 글로벌 헬스케어 컨퍼런스에서 발표할 예정이며, 발표자는 Erik Holmlin 박사입니다. 컨퍼런스의 다시 보기는 Bionano 웹사이트에서 이용 가능합니다.
Bionano Genomics, Inc. présentera à la Conférence Mondiale sur la Santé 2024 de RBC Capital Markets, avec Erik Holmlin, PhD, comme intervenant. La conférence aura lieu le 15 mai 2024 et un replay sera disponible sur le site web de Bionano.
Bionano Genomics, Inc. wird auf der RBC Capital Markets Global Healthcare Konferenz 2024 vortragen, mit Erik Holmlin, PhD, als Referent. Die Konferenz findet am 15. Mai 2024 statt und eine Wiederholung wird auf der Bionano-Website verfügbar sein.
Positive
None.
Negative
None.
SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the RBC Capital Markets 2024 Global Healthcare Conference on May 15, 2024.
A replay / recording of the session will be available following the conference through the Bionano website at https://ir.bionano.com/ for at least 30 days.
About Bionano
Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also provides OGM-based testing for certain laboratory developed tests. The Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. For more information, visit www.bionano.com and www.bionanolaboratories.com.
Unless specifically noted otherwise, Bionano’s OGM products are for research use only and not for use in diagnostic procedures.
CONTACTS
Company Contact: Erik Holmlin, CEO Bionano Genomics, Inc. +1 (858) 888-7610 eholmlin@bionano.com
Investor Relations: David Holmes Gilmartin Group +1 (858) 888-7625 IR@bionano.com
FAQ
When will Bionano Genomics present at the RBC Capital Markets 2024 Global Healthcare Conference?
Bionano Genomics will present at the RBC Capital Markets 2024 Global Healthcare Conference on May 15, 2024.
Who will be the presenter at the conference?
The presenter at the conference will be Erik Holmlin, PhD, who is the CEO of Bionano Genomics.
Where can I watch the webcast of the conference?
The webcast of the conference can be accessed through the registration link available on the Bionano Genomics website.
Will there be a replay of the conference available?
Yes, a replay of the session will be available on the Bionano website for at least 30 days following the conference.
at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. at bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality o
